What Happened?
Warren, NJ-based Bellerophon-Therapeutics Appointed Fabian Tenenbaum as Chief Executive Officer
About the Company
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases.
About the Person
Fabian Tenenbaum is Chief Executive Officer at Bellerophon Therapeutics. Previously, Fabian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile